-
Policy
Policy
Exclusive interviews with leading policymakers that convey the true policy message that impacts markets.
LATEST FROM POLICY: -
EM Policy
EM Policy
Exclusive interviews with leading policymakers that convey the true policy message that impacts markets.
LATEST FROM EM POLICY: -
G10 Markets
G10 Markets
Real-time insight on key fixed income and fx markets.
Launch MNI PodcastsFixed IncomeFI Markets AnalysisCentral Bank PreviewsFI PiFixed Income Technical AnalysisUS$ Credit Supply PipelineGilt Week AheadGlobal IssuanceEurozoneUKUSDeep DiveGlobal Issuance CalendarsEZ/UK Bond Auction CalendarEZ/UK T-bill Auction CalendarUS Treasury Auction CalendarPolitical RiskMNI Political Risk AnalysisMNI Political Risk - US Daily BriefMNI Political Risk - The week AheadElection Previews -
Emerging Markets
Emerging Markets
Real-time insight of emerging markets in CEMEA, Asia and LatAm region
-
Commodities
Commodities
Real-time insight of oil & gas markets
-
Credit
Credit
Real time insight of credit markets
-
Data
-
Global Macro
Global Macro
Actionable insight on monetary policy, balance sheet and inflation with focus on global issuance. Analysis on key political risk impacting the global markets.
Global MacroDM Central Bank PreviewsDM Central Bank ReviewsEM Central Bank PreviewsEM Central Bank ReviewsBalance Sheet AnalysisData AnalysisEurozone DataUK DataUS DataAPAC DataInflation InsightEmployment InsightGlobal IssuanceEurozoneUKUSDeep DiveGlobal Issuance Calendars EZ/UK Bond Auction Calendar EZ/UK T-bill Auction Calendar US Treasury Auction Calendar Chart Packs -
About Us
To read the full story
Sign up now for free trial access to this content.
Please enter your details below.
Why MNI
MNI is the leading provider
of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.
Real-time Actionable Insight
Get the latest on Central Bank Policy and FX & FI Markets to help inform both your strategic and tactical decision-making.
Free AccessRTE: 'EU-UK Making Progress On Key Aspects Of NI Protocol'
Tony Connelly at RTE tweets a lengthy update on the Northern Ireland protocol (edited for brevity):
- The EU and UK are making progress on key aspects of the NI Protocol, with signs that an agreement on the medicines issue could be found soon, @rtenews understands.
- Despite the tensions around the Protocol [...] there is said to be "broad progress" in negotiations between European Commission and UK officials at technical level. However, EU and UK officials are thought to remain far apart on the question of food safety and animal health when it comes to the movement of large, mixed consignments of food from GB depots to supermarkets and retailers in Northern Ireland.
- On the medicines question, it's understood the European Commission is close to finding a solution to the problem of placing UK medicines [...] on the market in NI, which is de facto in the single market. Last night the DUP leader Edwin Poots accused the Irish government of wanting to "starve" Northern Ireland of medicines, including cancer drugs, as well as food.
- Under the Protocol, it was envisaged that medicines produced in GB would ultimately have to be licensed to an "authorised holder" that would be located in Northern Ireland or in an EU member state. [...] The EU and UK agreed a grace period in December meaning the new requirements will be on hold until the end of this year
- However, it's understood the Commission is now looking at the possibility of permanently allowing medicines produced in GB to be licensed via authorised holders there, as opposed to Northern Ireland, so long as the drugs do not leave the North to be sold in the south.
- There are expectations that a meeting of the EU-UK Joint Committee, which implements the Protocol, will met some point between 10 and 15 June in order to add political momentum to the process.
- It's understood the UK has requested that the Joint Committee be held on a separate day to the inaugural meeting of the Joint Partnership Council, which will implement and oversee the free trade agreement concluded by both sides in December.
To read the full story
Sign up now for free trial access to this content.
Please enter your details below.
Why MNI
MNI is the leading provider
of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.